The Asian oncology therapeutics market is at the cusp of innovation and disruption. AUM Biosciences is committed to leading this disruption with our integrated approach to oncology drug development, which harnesses the power of precision medicine to accelerate development timelines, contain trial costs and improve patient outcomes.
Scientifically driven matching of the small molecule with its relevant cellular target helps in offering patients tangible, positive outcomes
Read more...Ability to look at the background biology or genetics of a tumour using smart data
Read more...Combination of new innovations in trial design to evolve the drug development process thereby matching treatment advances to specific patients
Read more...Converting complex input into simple and meaningful output helping to reduce costs and accelerate the drug development process
Read more...Pipeline of novel, targeted therapies with combinatorial treatment potential.
Learn More..Pioneering precision oncology treatment underlined by accessibility and affordability
Improving cancer management and treatment through niche therapeutics
Driving affordable and accessible cancer therapeutics for the Asian continent
Developing cancer therapeutics by harnessing the power of digital and precision medicine
AUM Biosciences expands pipeline with global license for first-in-class targeted cancer therapy
Read more..AUM Biosciences appoints Dr. Zou Bin as its Chief Scientific Officer in preparation for clinical development milestones
Read more..AUM Biosciences, C-CAMP join hands for cancer therapy
Read more..A message from AUM’s CMO and Leadership Team
Read more..We are looking to partner with industry leaders, research institutions and academicians in developing new treatments.
Partner with Us
